| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Freedman Joseph S. | 10% | $29,215,375 | 5,533,215 | Joseph S. Freedman | 24 Sep 2025 | |||
| MANCHESTER MANAGEMENT CO LLC | 9.2% | -15% | $40,756,586 | -$7,770,133 | 4,904,523 | -16% | MORGAN C. FRANK | 31 Dec 2025 |
| Beutel, Goodman & Co Ltd. | 8% | $23,947,504 | 4,058,899 | Beutel, Goodman & Co Ltd. | 30 Sep 2025 | |||
| DISBROW ROBERT | 7% | $21,052,085 | 3,568,150 | Robert Disbrow | 30 Sep 2025 |
As of 31 Dec 2025, 35 institutional investors reported holding 13,830,451 shares of EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX). This represents 26% of the company’s total 53,310,033 outstanding shares.
The largest institutional shareholders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares (EPRX) together control 26% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 7% | 3,709,373 | -8.6% | 0.17% | $27,926,000 |
| Balyasny Asset Management L.P. | 2.5% | 1,350,000 | 0% | 0.02% | $10,192,500 |
| Vivo Capital, LLC | 2.5% | 1,350,000 | 0% | 0.66% | $10,192,500 |
| SCOTIA CAPITAL INC. | 2.4% | 1,286,183 | +0.65% | 0.04% | $9,604,679 |
| GREAT POINT PARTNERS LLC | 2.3% | 1,200,000 | 0% | 2.9% | $9,060,000 |
| Point72 Asset Management, L.P. | 1.3% | 712,104 | 0.01% | $5,376,437 | |
| Ikarian Capital, LLC | 1.1% | 610,000 | 0.6% | $4,605,500 | |
| Squadron Capital Management LLC | 0.94% | 500,000 | 0% | 1.7% | $3,775,000 |
| Ally Bridge Group (NY) LLC | 0.75% | 397,895 | -57% | 4.8% | $3,004,107 |
| Velan Capital Investment Management LP | 0.66% | 352,000 | 0% | 1.5% | $2,657,600 |
| Affinity Asset Advisors, LLC | 0.56% | 300,000 | 0% | 0.16% | $2,265,000 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.52% | 278,064 | 0% | $2,090,765 | |
| BANK OF AMERICA CORP /DE/ | 0.48% | 253,321 | +456% | 0% | $1,912,574 |
| UBS Group AG | 0.41% | 220,024 | +130% | 0% | $1,661,181 |
| ROYAL BANK OF CANADA | 0.37% | 196,277 | -54% | 0% | $1,482,000 |
| SummitTX Capital, L.P. | 0.33% | 175,948 | 0.04% | $1,328,407 | |
| MARSHALL WACE, LLP | 0.3% | 158,133 | 0% | $1,193,905 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 156,331 | 0.03% | $1,180,299 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.29% | 155,766 | +628% | 0% | $1,168,000 |
| INGALLS & SNYDER LLC | 0.15% | 77,400 | +31% | 0.02% | $584,000 |
| GOLDMAN SACHS GROUP INC | 0.11% | 58,058 | +45% | 0% | $438,338 |
| CIBC WORLD MARKET INC. | 0.11% | 58,050 | +287% | 0% | $436,536 |
| RAYMOND JAMES FINANCIAL INC | 0.1% | 52,972 | +59% | 0% | $399,939 |
| Quadrature Capital Ltd | 0.08% | 43,186 | 0% | $325,625 | |
| BANK OF MONTREAL /CAN/ | 0.07% | 37,250 | 0% | 0% | $280,083 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 13,830,451 | $104,211,571 | +$5,872,102 | $7.55 | 35 |
| 2025 Q3 | 12,813,323 | $75,287,324 | +$63,953,992 | $5.90 | 27 |
| 2025 Q2 | 1,970,076 | $10,889,810 | -$1,049,985 | $5.76 | 14 |
| 2025 Q1 | 2,167,593 | $7,087,336 | +$1,118,946 | $3.28 | 11 |
| 2024 Q4 | 1,826,270 | $5,634,759 | +$50,501 | $3.17 | 9 |
| 2024 Q3 | 1,798,968 | $4,545,745 | +$185,000 | $2.63 | 8 |
| 2024 Q2 | 1,727,190 | $4,433,025 | +$4,433,025 | $2.58 | 8 |